SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19
PerkinElmer
JUNE 3, 2022
There is therefore an urgent need for the development of effective antivirals to complement vaccination efforts and prevent more severe disease, hospitalization, and death. 2 PF-07321332, which is now being tested in clinical trials, 3 is a nitrile-containing derivative of PF-00835231.
52 
Let's personalize your content